IMPLANTABLE DRUG-ELUTING DEVICES MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-5412 |   Medical Devices

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Implantable Drug-Eluting Devices Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES MARKET

7.1 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA IMPLANTABLE DRUG-ELUTING DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Pfizer

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Medtronic

16.3 Merck

16.4 Bayer AG

16.5 Johnson & Johnson

16.6 Abbott

16.7 Surmodics

16.8 Boston Scientific Corporation

16.9 Titan Pharmaceuticals Inc

16.10 BIOTRONIK

16.11 Allergan

16.12 Bausch & Lomb

16.13 REVA Medical

16.14 MicroPort Medical

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Segment by Type
- Implantable Drug Infusion Pumps
- Intraocular Drug-Eluting Devices
- Contraceptive Drug-Eluting Devices
- Drug-Eluting Stents
- Others

Segment by Application
- Diabetes
- Contraception
- HIV/AIDS Prevention
- Chronic Pain Management
- Cardiovascular
- Ophthalmology
- Oncology
- Others

Companies

Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan Pharmaceuticals Inc
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical
MicroPort Medical

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.